CRKL and colorectal cancer: Furthermore, HAPI analysis identified potentially novel oncogenes that hijack enhancers in trans, such as CRKL in the colorectal cancer cell line HT29 and FOXJ2 in the small cell lung cancer cell line NCIH2171 (Figs. 2D and S2A).